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pregnancy and in the cord blood of newborns
1,

1

2

Sevda YÜKSEL *, Ayşe Arzu YİĞİT
Department of Child Development, School of Health, Turgut Özal University, Ankara, Turkey
2
Faculty of Veterinary Medicine, Kırıkkale University, Kırıkkale, Turkey

Received: 19.11.2013

Accepted: 24.06.2014

Published Online: 01.04.2015

Printed: 30.04.2015

Background/aim: To determine whether levels of malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD), glutathione
peroxidase (GPx), and catalase (CAT) change during the 3 trimesters of pregnancy, and to compare the third trimester of pregnancy
with newborn cord blood in respect to the levels of MDA, NO, and antioxidant enzymes.
Materials and methods: Maternal blood samples were collected at 9–13, 22–26, and 36–40 weeks of gestation. Cord blood was collected
at the time of delivery.
Results: NO levels and GPx activity were higher in the second and third trimesters than in the first trimester. MDA level was lower in the
third trimester and SOD and CAT activities were lower in the second and third trimesters than the first trimester. In cord blood, MDA
and NO levels were lower while CAT and GPx activities were higher than in the third trimester of pregnancy.
Conclusion: These results suggest that the balance of free radical and antioxidant production during pregnancy ensures healthy fetus
growth and development.
Key words: Maternal blood, catalase, cord blood, glutathione peroxidase, malondialdehyde, nitric oxide, superoxide dismutase

1. Introduction
Reactive oxygen species (ROS) are generated during
aerobic respiration and metabolism. In response,
mammalian cells have developed antioxidant defense
mechanisms that prevent ROS-induced damage of lipids,
proteins, and DNA. If the balance between oxidative
stress and antioxidant defense deteriorates, pathological
processes develop (1).
The production of ROS and the activation of antioxidant
defense mechanisms are important components of female
reproductive physiology. During pregnancy, the placenta
supplies a connection between the maternal and fetal blood
streams in order to meet the respiration, alimentation,
and excretion needs of the fetus. Uterine blood flow must
increase to support placental and fetal growth throughout
the gestational period (2). Oxidative stress increases
during early pregnancy because the high metabolic rate
of the placenta causes increased generation of ROS (3).
Placental progesterone also induces the augmentation of
blood lipids and malondialdehyde (MDA) (4). When ROS
interact with polyunsaturated fatty acids in membranes or
lipoproteins, the lipid peroxidation (LPO) process begins
* Correspondence: sevdayuksel@gmail.com
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(5). ROS and LPO induce the oxidative disturbance that
is implicated in the pathogenesis of some diseases, such
as pregnancy-induced hypertension, preeclampsia, and
eclampsia. Although some studies reported that plasma
LPO levels decreased in the third trimester of pregnancy
(5,6,7), others reported the opposite (8,9).
For the fetus, delivery is an important stress that
involves passing from a hypoxic intrauterine environment
to a normoxic extrauterine environment (10). LPO and
antioxidant status change during delivery, and these
changes affect the fetus (8). Maternal LPO levels increase
before delivery and decrease 48 h postpartum (11). While
newborn cord blood has higher levels of ascorbic acid
than maternal blood, levels of other antioxidants, like
α-tocopherol, retinol, and β-carotene, are lower in cord
blood than in maternal blood (12).
Previous findings suggest that the method of delivery
(13,14), the kind of anesthesia (15), and the time of delivery
(16) affect oxidative stress in maternal and cord blood
(17,18). However, oxidant and antioxidant status have
not been studied over the course of normal pregnancy or
compared between maternal blood from late in pregnancy
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and newborn cord blood. The first objective of this study
was to determine whether levels of MDA, nitric oxide (NO),
and endogenous antioxidant status markers superoxide
dismutase (SOD), glutathione peroxidase (GPx), and
catalase (CAT) change during the 3 trimesters of pregnancy.
The second objective was to compare maternal blood in the
third trimester of pregnancy and newborn cord blood with
respect to the levels of MDA, NO, and antioxidant enzymes.
2. Materials and methods
This study was conducted in the Department of Obstetrics
and Gynecology at Fatih University Hospital. Participants
were recruited randomly from among pregnant women
admitted to the hospital. Written consent was obtained
from all participants, and the study was approved by the
local ethics committee (2009/13).
All participants were 20–30 years old, nulliparous,
healthy, and nonsmoking. Participants also had similar
weights. All participants had uncomplicated singleton
pregnancies and delivered vaginally without anesthesia
between 38 and 40 weeks of pregnancy. None of the
participants had any complications during delivery.
Blood samples were collected from 30 healthy pregnant
women and their umbilical cords. Maternal blood samples
were obtained in the first trimester (9–13 weeks), second
trimester (22–26 weeks), and third trimester (36–40 weeks)
of gestation. Mixed venous and arterial cord blood was
obtained at the time of delivery by double-clamping of the
umbilical cord. Samples were centrifuged at 1000 × g for 10
min at 4 °C, and plasma was separated and stored at –80 °C
for determination of MDA and NO levels. The buffy coat
was removed and discarded. The remaining erythrocytes
were lysed by the addition of cold distilled water and
centrifuged at 10,000 × g for 15 min at 4 °C. Supernatant
was collected and stored at –80 °C for determination of
antioxidant enzyme activities.
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3. Results
As shown in Figure 1, MDA levels were lower in the third
trimester than they were in the first and second trimesters
(P < 0.001). The NO level was higher in the third trimester
than in the first and second trimesters (P < 0.001) (Figure
2). In the second and third trimesters, CAT activity was
lower than in the first trimester (P < 0.05) (Figure 3). GPx
activity was significantly higher (P < 0.05) in the second
and third trimesters than in the first trimester (Figure 4).
SOD activity decreased over the course of pregnancy as
shown in Figure 5 (P < 0.05).
As shown in Figure 6, plasma MDA and NO levels
were lower (P < 0.001 and P < 0.05, respectively) and
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Plasma MDA and NO levels were measured using
colorimetric assay kits (Cat. No. 10009055 and 780001,
respectively, Cayman Chemical Company, USA). CAT,
SOD, and GPx activities in erythrocyte lysates were
measured with commercial kits from the same company
(Catalog No. 707002, 706002, and 703102, respectively,
Cayman Chemical Company). The hemoglobin (Hb)
contents of erythrocyte lysates were measured using a
Cromatest kit (Catalog No. 1134010, Linear Chemicals,
Spain). Antioxidant enzyme activities are expressed as U/g
Hb concentration.
Data were expressed as the mean and standard error
(X ± SEM). Statistical analysis was performed using
SAS version 8.02 (SAS Institute, USA). Data from the 3
trimesters of pregnancy were analyzed using the general
linear model. Duncan’s multiple range test was used to
identify differences between groups. The significance
of differences between maternal blood from the third
trimester of pregnancy and cord blood was assessed using
Student’s t-test. Differences were considered significant
when the P-value was less than 0.05. Figures were drawn
with Origin 6.0.

Malondialdehyde level

Figure 1. Plasma MDA levels in different trimesters of pregnancy
(n = 30). a, b: P < 0.001.

0

Nitric oxide level

Figure 2. Plasma NO levels in different trimesters of pregnancy
(n = 30). a, b: P < 0.001.
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Catalase activity

Figure 3. Erythrocyte CAT activity in different trimesters of
pregnancy (n = 30). a, b: P < 0.05.
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Figure 4. Erythrocyte GPx activity in different trimesters of
pregnancy (n = 30). a, b, c: P < 0.05.
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Figure 5. Erythrocyte SOD activity in different trimesters of
pregnancy (n = 30). a, b, c: P < 0.05.

Figure 6. Comparison of MDA and NO levels and CAT, SOD,
and GPx activities in maternal blood from the third trimester of
pregnancy and newborn cord blood (n = 30). * P < 0.05, ** P < 0.001.

CAT and GPx activities were higher (P < 0.05) in the cord
blood than in the maternal blood. There was no significant
difference in SOD activity between maternal blood in the
third trimester and cord blood (P > 0.05).

large number of mitochondria (21). ROS are produced as
a consequence of tissue reoxygenation, and increased LPO
causes maternal oxidative stress (22). However, increased
antioxidant enzyme activity inactivates ROS and decreases
LPO. This balance between the production of ROS and
activation of antioxidant mechanisms protects the tissues
from damage and prevents disorders. Stipek et al. (22) and
Uotila et al. (23) reported that the antioxidant system was
stronger than peroxidation during pregnancy. Although
some reports (9,24,25) showed that LPO increased during
the course of pregnancy, other reports (6,23) observed
that LPO decreased as pregnancy progressed. In normal
pregnancy, placental lipid production is controlled by
placental antioxidant systems (26). MDA, a metabolite
of lipid peroxides, is detectable in plasma and is used as
an indicator of LPO. Mihailovic et al. (27) reported an

4. Discussion
There are many anatomical, physiological, biochemical,
and psychological changes that occur during pregnancy to
protect the mother from the risks of gestation and delivery
and to ensure the healthy growth and development of the
fetus. These changes are reversed during the 6–8 weeks
following delivery (19).
There is a balance between the production of ROS and
antioxidant status in the predelivery period (20). Oxidative
stress increases during pregnancy because of the increased
oxygen requirements of the placenta, which contains a
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inverse correlation between GPx activity and MDA levels
during pregnancy. In the current study, decreased MDA
concentrations in the third trimester of pregnancy could
be due to increased GPx activity. These findings (Figure 1)
are in agreement with previous reports (6,7,23).
In the present study, cord blood had lower MDA levels
than maternal blood from the third trimester of pregnancy.
This result is consistent with the findings reported by
Upadhyaya et al. (12) and Saker et al. (20). Increased CAT
and GPx activities might lead to reduced MDA levels in
cord blood.
NO is a biological vasodilator, synthesized from
L-arginine by endothelial nitric oxide synthase (28).
Previous studies have reported conflicting results
pertaining to NO levels in pregnancy. Hata et al. (29)
reported that NO levels decreased during pregnancy, and
Brown et al. (30) and Smarason et al. (31) reported that
there were no changes in NO levels over the course of
pregnancy. In the present study, NO levels in maternal blood
significantly increased during pregnancy, and maternal
blood in the third trimester of pregnancy had higher
NO levels than cord blood. These findings are consistent
with the results of some previous studies (14,32,33,34).
There is an increased need for NO during pregnancy to
support the arrangement of vascular functions in both the
developing placental tissue and the developing fetus (35).
Previous studies (32,33) also suggested that NO controls
the contractility of the uterus. When delivery begins
and uterine contractility increases, the NO requirement
diminishes (36). Karabulut et al. (28) and Choi et al. (31)
reported that NO levels in maternal blood decreased after
delivery and returned to prepregnancy levels in 9–12
weeks. Consistent with these reports, the increased third
trimester NO levels observed in this study could support
the increased NO requirements of the placental and fetal
tissues and the myometrial relaxation that is necessary for
continuing pregnancy.
CAT, SOD, and GPx are important components of
the antioxidant defense system. They control the level
of free radicals in cells. Although Ademuyiwa et al. (37)
reported that CAT activity did not change, Djordjevic et
al. (38) showed increased CAT activity during the course
of pregnancy. Our finding that CAT activity in maternal
blood decreases during pregnancy is consistent with
studies carried out in pregnant ewes (39,40). The decreased
activity of CAT could be due to decreases in LPO in the
third trimester of pregnancy.
In the present study, GPX activity was higher in the
second and third trimesters than in the first trimester. This
result is consistent with the findings of Mihailovic et al.
(26) and Cochrane (41), who reported that GPx activity
increased during pregnancy. Gutman et al. (42) reported
that increased GPx activity in pregnancy is a defense

mechanism to protect the fetus against the harmful effects
of hydrogen peroxide. The results of the current study
suggest that increased GPx activity suppresses the MDA
level in the third trimester of pregnancy in order to protect
the fetus.
Novak et al. (43) reported that CAT activity in cord
blood was significantly lower than in maternal blood before
delivery. In contrast, our findings are consistent with other
studies (6,44,45,46), which reported that CAT and GPx
activities were higher in cord blood than in maternal blood
during the third trimester. The significant elevation in
cord blood CAT and GPx activities observed in this study
suggests that these enzymes prevent the accumulation of
toxic molecules, protecting the fetus from the effects of
ROS and promoting normal fetal development.
SOD activity decreased during the course of pregnancy
in the present study. Similar findings were reported
by Wisdom et al. (47). The observed decrease in SOD
activity over the course of pregnancy may be due to the
corresponding decrease in MDA levels.
Some previous studies reported no significant
differences in SOD activity between maternal blood and
cord blood (48,49,50). In the present study, we confirmed
those findings. In contrast, several researchers reported
decreased SOD activity in cord blood (51) and newborn
blood (20), and other studies (11,43,44,45,52) reported
increased SOD activity in cord blood. These differences
may arise from the balance of oxidant and antioxidant
systems (53,54,55).
In this study, we found that while maternal MDA levels
and CAT and SOD activities decreased during pregnancy,
NO levels and GPx activity increased. These results indicate
that both peroxidation and antioxidant protection, with
the exception of GPx activity, decreased during pregnancy.
Increased GPx activity in late pregnancy suggests that GPx
plays an important role in reducing MDA levels in the
third trimester of pregnancy and it provides the balance of
oxidant and antioxidant systems. We posit that NO levels
increase during pregnancy to support necessary vascular
functions in placental and fetal tissues. When comparing
the maternal blood in late pregnancy to newborn cord
blood, a negative correlation is found between oxidative
stress and CAT and GPx that also supports the existence
of an oxidant/antioxidant balance. As a result of this
study, we infer that the antioxidant system provides the
maintaining of pregnancy and the antioxidant capacity of
the cord blood is sufficient to protect the baby from the
oxidative stress of delivery.
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